GHB (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "GHB" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

35nih.gov

4^th place

11^th place

28doi.org

2^nd place

8^th place

8web.archive.org

1^st place

7archive.org

6^th place

14^th place

4aspetjournals.org

6,663^rd place

low place

2elsevier.com

610^th place

1,534^th place

2reuters.com

49^th place

131^st place

1erowid.org

3,887^th place

2,676^th place

1emedicine.com

3,595^th place

1,926^th place

1usdoj.gov

2,755^th place

8,286^th place

1edk.fr

low place

1if-pan.krakow.pl

low place

1bio.net

low place

1biopsychiatry.com

low place

1jazzpharma.com

low place

1prohealth.com

low place

1udel.edu

4,858^th place

low place

1independent.co.uk

36^th place

114^th place

1ajcn.org

low place

2,649^th place

1rarediseases.org

5,181^st place

low place

1aafs.org

low place

1bbc.co.uk

8^th place

21^st place

1wiley.com

222^nd place

312^th place

1cambridge.org

305^th place

682^nd place

aafs.org

Zvosec et al. American Academy of Forensic Science in Seattle, 2006. [2007. december 3-i dátummal az eredetiből archiválva]. (Hozzáférés: 2007. december 3.)

ajcn.org

Pangborn RM, Pecore SD (1982. March). „Taste perception of sodium chloride in relation to dietary intake of salt”. Am. J. Clin. Nutr. 35 (3), 510–20. o. PMID 7064902.

archive.org

Weil, Andrew, Winifred Rosen. Depressants, From Chocolate to Morphine, 2nd, Boston/New York: Houghton Mifflin Company, 77. o. (1993). ISBN 0-395-66079-3
Witkowski, Mark R.; Ciolino, Laura A.; De Francesco, James V. (2006). „GHB Free Acid: II. Isolation and Spectroscopic Characterization for Forensic Analysis”. Journal of Forensic Sciences 51, 330. o. DOI:10.1111/j.1556-4029.2006.00074.x.
Riccardo Volpi, Paolo Chiodera, Paolo Caffarra, Augusto Scaglioni, Antonella Saccani and Vittorio Coiro (1997). „Different control mechanisms of growth hormone (GH) secretion between γ-amino- and γ-hydroxy-butyric acid: neuroendocrine evidence in parkinson's disease”. Psychoneuroendocrinology 22 (7), 531–538. o. DOI:10.1016/S0306-4530(97)00055-3.
Volpi, R (2000). „Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects”. Psychoneuroendocrinology 25, 179. o. DOI:10.1016/S0306-4530(99)00048-7.
Badamchian, M (1995). „Alpha-Tocopherol Succinate, But Not Alpha-Tocopherol Or Other Vitamin E Analogs Stimulates Prolactin And Growth Hormone Release From Rat Anterior Pituitary Cells in vitro”. The Journal of Nutritional Biochemistry 6, 340. o. DOI:10.1016/0955-2863(95)00044-Z.
C. Andriamampandry, O. Taleb, S. Viry, C. Muller, J. P. Humbert, S. Gobaille, D. Aunis and M. Maitre (2003). „Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator γ-hydroxybutyrate”. The FASEB Journal 17 (12), 1691–3. o. DOI:10.1096/fj.02-0846fje. PMID 12958178.
Carai, M.A.M., Colombo, G.; Gessa, G.L. (2005). „Resuscitative Effect of a γ-Aminobutyric Acid B Receptor Antagonist on γ-Hydroxybutyric Acid Mortality in Mice”. Annals of Emergency Medicine 45 (6), 614–619. o. DOI:10.1016/j.annemergmed.2004.12.013. PMID 15940094.

aspetjournals.org

jpet.aspetjournals.org

Banerjee PK, Snead OC (1995. June). „Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB (GABA_B) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB”. J. Pharmacol. Exp. Ther. 273 (3), 1534–43. o. PMID 7791129.
Maitre M, Hechler V, Vayer P, et al. (1990. November). „A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties”. J. Pharmacol. Exp. Ther. 255 (2), 657–63. o. PMID 2173754.
Wu, H. (2003). „A Tertiary Alcohol Analog of gamma-Hydroxybutyric Acid as a Specific gamma -Hydroxybutyric Acid Receptor Ligand”. Journal of Pharmacology and Experimental Therapeutics 305, 675. o. DOI:10.1124/jpet.102.046797. PMID 12606613.
Gobaille S, Hechler V, Andriamampandry C, Kemmel V, Maitre M (1999. July). „gamma-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo”. J. Pharmacol. Exp. Ther. 290 (1), 303–9. o. PMID 10381791.

bbc.co.uk

news.bbc.co.uk

Science and Technology Committee Report (p. 176), 2006)

bio.net

OTC GABA és a vér-agy-gát

biopsychiatry.com

Xyrem drug data sheet.

cambridge.org

journals.cambridge.org

Pedraza C, García FB, Navarro JF (2009. October). „Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats”. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 12 (9), 1165–77. o. DOI:10.1017/S1461145709000157. PMID 19288974. ^{[halott link]}

doi.org

dx.doi.org

Wu Y, Ali S, Ahmadian G, et al. (2004. December). „Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence”. Neuropharmacology 47 (8), 1146–56. o. DOI:10.1016/j.neuropharm.2004.08.019. PMID 15567424.
Cash, C (1999). „γ-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches”. Biochemical Pharmacology 58, 1815. o. DOI:10.1016/S0006-2952(99)00265-8.
Dimitrijevic N, Dzitoyeva S, Satta R, Imbesi M, Yildiz S, Manev H (2005. September). „Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB)”. Eur. J. Pharmacol. 519 (3), 246–52. o. DOI:10.1016/j.ejphar.2005.07.016. PMID 16129424.
Castelli MP, Ferraro L, Mocci I, et al. (2003. November). „Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid”. J. Neurochem. 87 (3), 722–32. o. DOI:10.1046/j.1471-4159.2003.02037.x. PMID 14535954.
Hechler V, Gobaille S, Bourguignon JJ, Maitre M (1991. March). „Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study”. J. Neurochem. 56 (3), 938–44. o. DOI:10.1111/j.1471-4159.1991.tb02012.x. PMID 1847191.
Smolders I, De Klippel N, Sarre S, Ebinger G, Michotte Y (1995. September). „Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat”. Eur. J. Pharmacol. 284 (1-2), 83–91. o. DOI:10.1016/0014-2999(95)00369-V. PMID 8549640.
Mamelak M (1989). „Gammahydroxybutyrate: an endogenous regulator of energy metabolism”. Neurosci Biobehav Rev 13 (4), 187–98. o. DOI:10.1016/S0149-7634(89)80053-3. PMID 2691926.
Wu, H. (2003). „A Tertiary Alcohol Analog of gamma-Hydroxybutyric Acid as a Specific gamma -Hydroxybutyric Acid Receptor Ligand”. Journal of Pharmacology and Experimental Therapeutics 305, 675. o. DOI:10.1124/jpet.102.046797. PMID 12606613.
Jones, C. (2001). „Suspicious death related to gamma-hydroxybutyrate (GHB) toxicity (2001)”. Journal of Clinical Forensic Medicine 8, 74. o. DOI:10.1054/jcfm.2001.0473.
Witkowski, Mark R.; Ciolino, Laura A.; De Francesco, James V. (2006). „GHB Free Acid: II. Isolation and Spectroscopic Characterization for Forensic Analysis”. Journal of Forensic Sciences 51, 330. o. DOI:10.1111/j.1556-4029.2006.00074.x.
Riccardo Volpi, Paolo Chiodera, Paolo Caffarra, Augusto Scaglioni, Antonella Saccani and Vittorio Coiro (1997). „Different control mechanisms of growth hormone (GH) secretion between γ-amino- and γ-hydroxy-butyric acid: neuroendocrine evidence in parkinson's disease”. Psychoneuroendocrinology 22 (7), 531–538. o. DOI:10.1016/S0306-4530(97)00055-3.
Volpi, R (2000). „Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects”. Psychoneuroendocrinology 25, 179. o. DOI:10.1016/S0306-4530(99)00048-7.
Badamchian, M (1995). „Alpha-Tocopherol Succinate, But Not Alpha-Tocopherol Or Other Vitamin E Analogs Stimulates Prolactin And Growth Hormone Release From Rat Anterior Pituitary Cells in vitro”. The Journal of Nutritional Biochemistry 6, 340. o. DOI:10.1016/0955-2863(95)00044-Z.
Kemmel V, Taleb O, Perard A, et al. (1998. October). „Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB-20 neurons”. Neuroscience 86 (3), 989–1000. o. DOI:10.1016/S0306-4522(98)00085-2. PMID 9692734.
C. Andriamampandry, O. Taleb, S. Viry, C. Muller, J. P. Humbert, S. Gobaille, D. Aunis and M. Maitre (2003). „Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator γ-hydroxybutyrate”. The FASEB Journal 17 (12), 1691–3. o. DOI:10.1096/fj.02-0846fje. PMID 12958178.
Maitre M, Ratomponirina C, Gobaille S, Hodé Y, Hechler V (1994. April). „Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics”. Eur. J. Pharmacol. 256 (2), 211–4. o. DOI:10.1016/0014-2999(94)90248-8. PMID 7914168.
Ottani A, Saltini S, Bartiromo M, et al. (2003. October). „Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage”. Brain Res. 986 (1–2), 181–90. o. DOI:10.1016/S0006-8993(03)03252-9. PMID 12965243.
(2009) „Three deaths associated with use of Xyrem.”. Sleep medicine 10 (4), 490–493. o. DOI:10.1016/j.sleep.2009.01.005. PMID 19269893.
Feldman NT (2009. April). „Xyrem safety: the debate continues”. Sleep Med. 10 (4), 405–6. o. DOI:10.1016/j.sleep.2009.02.002. PMID 19332385.
(2010) „Response to Editorial: "Xyrem safety: the debate continues"”. Sleep medicine 11 (1), 108; author reply 108–9. o. DOI:10.1016/j.sleep.2009.08.004. PMID 19959395.
Allen, L., Alsalim, W. (2006. április 1.). „Gammahydroxybutyrate overdose and physostigmine”. Emergency Medicine Journal 23 (4), 300. o. DOI:10.1136/emj.2006.035139. PMID 16549578. PMC 2579509.
Michael, H., Harrison, M. (2005. január 1.). „Endotracheal intubation in γ-hydroxybutyric acid intoxication and overdose”. Emergency Medicine Journal 22 (1), 43. o. DOI:10.1136/emj.2004.021154. PMID 15611542. PMC 1726538.
Carai, M.A.M., Colombo, G.; Gessa, G.L. (2005). „Resuscitative Effect of a γ-Aminobutyric Acid B Receptor Antagonist on γ-Hydroxybutyric Acid Mortality in Mice”. Annals of Emergency Medicine 45 (6), 614–619. o. DOI:10.1016/j.annemergmed.2004.12.013. PMID 15940094.
Sircar R, Basak A (2004. December). „Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-D-aspartate receptor and impairs spatial learning”. Pharmacology, Biochemistry, and Behavior 79 (4), 701–8. o. DOI:10.1016/j.pbb.2004.09.022. PMID 15582677.
Sircar R, Basak A, Sircar D (2008. October). „Gamma-hydroxybutyric acid-induced cognitive deficits in the female adolescent rat”. Annals of the New York Academy of Sciences 1139, 386–9. o. DOI:10.1196/annals.1432.044. PMID 18991885. ^{[halott link]}
Pedraza C, García FB, Navarro JF (2009. October). „Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats”. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 12 (9), 1165–77. o. DOI:10.1017/S1461145709000157. PMID 19288974. ^{[halott link]}
Sgaravatti AM, Sgarbi MB, Testa CG, et al. (2007. February). „Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats”. Neurochemistry International 50 (3), 564–70. o. DOI:10.1016/j.neuint.2006.11.007. PMID 17197055.
Sgaravatti AM, Magnusson AS, Oliveira AS, et al. (2009. June). „Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo”. Metabolic Brain Disease 24 (2), 271–82. o. DOI:10.1007/s11011-009-9136-7. PMID 19296210.

edk.fr

Maitre M, Humbert JP, Kemmel V, Aunis D, Andriamampandry C (2005. March). „[A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse]” (francia nyelven). Med Sci (Paris) 21 (3), 284–9. o. [2009. július 15-i dátummal az eredetiből archiválva]. PMID 15745703. (Hozzáférés: 2008. november 20.)

elsevier.com

linkinghub.elsevier.com

Sircar R, Basak A (2004. December). „Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-D-aspartate receptor and impairs spatial learning”. Pharmacology, Biochemistry, and Behavior 79 (4), 701–8. o. DOI:10.1016/j.pbb.2004.09.022. PMID 15582677.
Sgaravatti AM, Sgarbi MB, Testa CG, et al. (2007. February). „Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats”. Neurochemistry International 50 (3), 564–70. o. DOI:10.1016/j.neuint.2006.11.007. PMID 17197055.

emedicine.com

Theodore I Benzer: Toxicity, Gamma-Hydroxybutyrate. eMedicine, 2007. január 8.

erowid.org

Erowid GHB Vault : Törvényi státusza

if-pan.krakow.pl

Waszkielewicz A, Bojarski J (2004). „Gamma-hydrobutyric acid (GHB) and its chemical modifications: a review of the GHBergic system” (PDF). Pol J Pharmacol 56 (1), 43–9. o. PMID 15047976.

independent.co.uk

"Labs making date-rape drug raided", The Independent World, 10 July 2008.

jazzpharma.com

investor.jazzpharma.com

http://investor.jazzpharma.com/phoenix.zhtml?c=210227&p=irol-newsArticle&id=1243912^{[halott link]}

nih.gov

pubmed.ncbi.nlm.nih.gov

Wu Y, Ali S, Ahmadian G, et al. (2004. December). „Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence”. Neuropharmacology 47 (8), 1146–56. o. DOI:10.1016/j.neuropharm.2004.08.019. PMID 15567424.
Maitre M, Humbert JP, Kemmel V, Aunis D, Andriamampandry C (2005. March). „[A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse]” (francia nyelven). Med Sci (Paris) 21 (3), 284–9. o. [2009. július 15-i dátummal az eredetiből archiválva]. PMID 15745703. (Hozzáférés: 2008. november 20.)
Waszkielewicz A, Bojarski J (2004). „Gamma-hydrobutyric acid (GHB) and its chemical modifications: a review of the GHBergic system” (PDF). Pol J Pharmacol 56 (1), 43–9. o. PMID 15047976.
Kuriyama K, Sze PY (1971. January). „Blood-brain barrier to H3-gamma-aminobutyric acid in normal and amino oxyacetic acid-treated animals”. Neuropharmacology 10 (1), 103–8. o. PMID 5569303.
Dimitrijevic N, Dzitoyeva S, Satta R, Imbesi M, Yildiz S, Manev H (2005. September). „Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB)”. Eur. J. Pharmacol. 519 (3), 246–52. o. DOI:10.1016/j.ejphar.2005.07.016. PMID 16129424.
Castelli MP, Ferraro L, Mocci I, et al. (2003. November). „Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid”. J. Neurochem. 87 (3), 722–32. o. DOI:10.1046/j.1471-4159.2003.02037.x. PMID 14535954.
Banerjee PK, Snead OC (1995. June). „Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB (GABA_B) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB”. J. Pharmacol. Exp. Ther. 273 (3), 1534–43. o. PMID 7791129.
Hechler V, Gobaille S, Bourguignon JJ, Maitre M (1991. March). „Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study”. J. Neurochem. 56 (3), 938–44. o. DOI:10.1111/j.1471-4159.1991.tb02012.x. PMID 1847191.
Maitre M, Hechler V, Vayer P, et al. (1990. November). „A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties”. J. Pharmacol. Exp. Ther. 255 (2), 657–63. o. PMID 2173754.
Smolders I, De Klippel N, Sarre S, Ebinger G, Michotte Y (1995. September). „Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat”. Eur. J. Pharmacol. 284 (1-2), 83–91. o. DOI:10.1016/0014-2999(95)00369-V. PMID 8549640.
Mamelak M (1989). „Gammahydroxybutyrate: an endogenous regulator of energy metabolism”. Neurosci Biobehav Rev 13 (4), 187–98. o. DOI:10.1016/S0149-7634(89)80053-3. PMID 2691926.
Wu, H. (2003). „A Tertiary Alcohol Analog of gamma-Hydroxybutyric Acid as a Specific gamma -Hydroxybutyric Acid Receptor Ligand”. Journal of Pharmacology and Experimental Therapeutics 305, 675. o. DOI:10.1124/jpet.102.046797. PMID 12606613.
ElSohly MA, Salamone SJ (1999). „Prevalence of drugs used in cases of alleged sexual assault”. J Anal Toxicol 23 (3), 141–6. o. PMID 10369321.
Pangborn RM, Pecore SD (1982. March). „Taste perception of sodium chloride in relation to dietary intake of salt”. Am. J. Clin. Nutr. 35 (3), 510–20. o. PMID 7064902.
Kemmel V, Taleb O, Perard A, et al. (1998. October). „Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB-20 neurons”. Neuroscience 86 (3), 989–1000. o. DOI:10.1016/S0306-4522(98)00085-2. PMID 9692734.
C. Andriamampandry, O. Taleb, S. Viry, C. Muller, J. P. Humbert, S. Gobaille, D. Aunis and M. Maitre (2003). „Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator γ-hydroxybutyrate”. The FASEB Journal 17 (12), 1691–3. o. DOI:10.1096/fj.02-0846fje. PMID 12958178.
Maitre M, Ratomponirina C, Gobaille S, Hodé Y, Hechler V (1994. April). „Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics”. Eur. J. Pharmacol. 256 (2), 211–4. o. DOI:10.1016/0014-2999(94)90248-8. PMID 7914168.
Gobaille S, Hechler V, Andriamampandry C, Kemmel V, Maitre M (1999. July). „gamma-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo”. J. Pharmacol. Exp. Ther. 290 (1), 303–9. o. PMID 10381791.
Ottani A, Saltini S, Bartiromo M, et al. (2003. October). „Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage”. Brain Res. 986 (1–2), 181–90. o. DOI:10.1016/S0006-8993(03)03252-9. PMID 12965243.
Poldrugo F, Addolorato G (1999). „The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies”. Alcohol Alcohol. 34 (1), 15–24. o. PMID 10075397.
(2009) „Three deaths associated with use of Xyrem.”. Sleep medicine 10 (4), 490–493. o. DOI:10.1016/j.sleep.2009.01.005. PMID 19269893.
Feldman NT (2009. April). „Xyrem safety: the debate continues”. Sleep Med. 10 (4), 405–6. o. DOI:10.1016/j.sleep.2009.02.002. PMID 19332385.
(2010) „Response to Editorial: "Xyrem safety: the debate continues"”. Sleep medicine 11 (1), 108; author reply 108–9. o. DOI:10.1016/j.sleep.2009.08.004. PMID 19959395.
Allen, L., Alsalim, W. (2006. április 1.). „Gammahydroxybutyrate overdose and physostigmine”. Emergency Medicine Journal 23 (4), 300. o. DOI:10.1136/emj.2006.035139. PMID 16549578. PMC 2579509.
Michael, H., Harrison, M. (2005. január 1.). „Endotracheal intubation in γ-hydroxybutyric acid intoxication and overdose”. Emergency Medicine Journal 22 (1), 43. o. DOI:10.1136/emj.2004.021154. PMID 15611542. PMC 1726538.
Carai, M.A.M., Colombo, G.; Gessa, G.L. (2005). „Resuscitative Effect of a γ-Aminobutyric Acid B Receptor Antagonist on γ-Hydroxybutyric Acid Mortality in Mice”. Annals of Emergency Medicine 45 (6), 614–619. o. DOI:10.1016/j.annemergmed.2004.12.013. PMID 15940094.
Sircar R, Basak A (2004. December). „Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-D-aspartate receptor and impairs spatial learning”. Pharmacology, Biochemistry, and Behavior 79 (4), 701–8. o. DOI:10.1016/j.pbb.2004.09.022. PMID 15582677.
García FB, Pedraza C, Arias JL, Navarro JF (2006. August). „[Effects of subchronic administration of gammahydroxybutyrate (GHB) on spatial working memory in rats]” (kasztíliai spanyol nyelven). Psicothema 18 (3), 519–24. o. PMID 17296081.
Sircar R, Basak A, Sircar D (2008. October). „Gamma-hydroxybutyric acid-induced cognitive deficits in the female adolescent rat”. Annals of the New York Academy of Sciences 1139, 386–9. o. DOI:10.1196/annals.1432.044. PMID 18991885. ^{[halott link]}
Pedraza C, García FB, Navarro JF (2009. October). „Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats”. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 12 (9), 1165–77. o. DOI:10.1017/S1461145709000157. PMID 19288974. ^{[halott link]}
Sgaravatti AM, Sgarbi MB, Testa CG, et al. (2007. February). „Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats”. Neurochemistry International 50 (3), 564–70. o. DOI:10.1016/j.neuint.2006.11.007. PMID 17197055.
Sgaravatti AM, Magnusson AS, Oliveira AS, et al. (2009. June). „Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo”. Metabolic Brain Disease 24 (2), 271–82. o. DOI:10.1007/s11011-009-9136-7. PMID 19296210.

ncbi.nlm.nih.gov

Allen, L., Alsalim, W. (2006. április 1.). „Gammahydroxybutyrate overdose and physostigmine”. Emergency Medicine Journal 23 (4), 300. o. DOI:10.1136/emj.2006.035139. PMID 16549578. PMC 2579509.
Michael, H., Harrison, M. (2005. január 1.). „Endotracheal intubation in γ-hydroxybutyric acid intoxication and overdose”. Emergency Medicine Journal 22 (1), 43. o. DOI:10.1136/emj.2004.021154. PMID 15611542. PMC 1726538.

ntp.niehs.nih.gov

National Toxicology Program: Toxicology and Carcinogenesis Studies of g-Butyrolactone (CAS No. 96-48-0) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Study Reports. Department of Health and Human Services, NIH, March 1992

prohealth.com

http://www.prohealth.com/library/showarticle.cfm?libid=13910

rarediseases.org

National Organization for Rare Disorders. Succinic Semialdehyde Dehydrogenase Deficiency. Accessed 6 March 2010.

reuters.com

stocks.us.reuters.com

Jazz Pharmaceuticals Inc (JAZZ.O) Full Description | Stocks | Reuters.com. [2008. május 22-i dátummal az eredetiből archiválva]. (Hozzáférés: 2010. június 14.)

reuters.com

Archivált másolat. [2010. február 13-i dátummal az eredetiből archiválva]. (Hozzáférés: 2010. június 14.)

udel.edu

S.O.S. - Date Rape Drugs Archiválva 2008. október 7-i dátummal a Wayback Machine-ben.

usdoj.gov

GHB, GBL and 1,4BD as Date Rape Drugs.

web.archive.org

Jazz Pharmaceuticals Inc (JAZZ.O) Full Description | Stocks | Reuters.com. [2008. május 22-i dátummal az eredetiből archiválva]. (Hozzáférés: 2010. június 14.)
Maitre M, Humbert JP, Kemmel V, Aunis D, Andriamampandry C (2005. March). „[A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse]” (francia nyelven). Med Sci (Paris) 21 (3), 284–9. o. [2009. július 15-i dátummal az eredetiből archiválva]. PMID 15745703. (Hozzáférés: 2008. november 20.)
Archivált másolat. [2010. február 13-i dátummal az eredetiből archiválva]. (Hozzáférés: 2010. június 14.)
http://investor.jazzpharma.com/phoenix.zhtml?c=210227&p=irol-newsArticle&id=1243912^{[halott link]}
S.O.S. - Date Rape Drugs Archiválva 2008. október 7-i dátummal a Wayback Machine-ben.
Zvosec et al. American Academy of Forensic Science in Seattle, 2006. [2007. december 3-i dátummal az eredetiből archiválva]. (Hozzáférés: 2007. december 3.)
Sircar R, Basak A, Sircar D (2008. October). „Gamma-hydroxybutyric acid-induced cognitive deficits in the female adolescent rat”. Annals of the New York Academy of Sciences 1139, 386–9. o. DOI:10.1196/annals.1432.044. PMID 18991885. ^{[halott link]}
Pedraza C, García FB, Navarro JF (2009. October). „Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats”. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 12 (9), 1165–77. o. DOI:10.1017/S1461145709000157. PMID 19288974. ^{[halott link]}

wiley.com

www3.interscience.wiley.com

Sircar R, Basak A, Sircar D (2008. October). „Gamma-hydroxybutyric acid-induced cognitive deficits in the female adolescent rat”. Annals of the New York Academy of Sciences 1139, 386–9. o. DOI:10.1196/annals.1432.044. PMID 18991885. ^{[halott link]}